ToxAI: Revolutionizing Toxicity Prediction with Machine Learning

An in-house machine learning tool for predictive safety intelligence in drug discovery

ToxAI is a cutting-edge toxicity prediction tool developed entirely in-house as part of the SilicoXplore platform. Built from the ground up using advanced machine learning techniques and proprietary algorithms, ToxAI enables accurate and fast prediction of key toxicity endpoints that predict toxicities of chemical compounds while ensuring adherence to key drug-likeness criteria such as Lipinski's Rule and Veber Rule.

Designed to support early-stage drug discovery, ToxAI helps identify and eliminate potentially harmful compounds before costly experimental stages. It accepts molecular inputs via SMILES and integrates seamlessly with other modules in SilicoXplore — including ADME profiling, docking, conformer generation, and de novo compound design — for a holistic compound evaluation workflow.

With ToxAI, researchers gain a powerful, AI-powered layer of safety intelligence to accelerate development while ensuring safer therapeutic candidates.